93 related articles for article (PubMed ID: 27222255)
1. Downregulation of lncRNA CASC2 by microRNA-21 increases the proliferation and migration of renal cell carcinoma cells.
Cao Y; Xu R; Xu X; Zhou Y; Cui L; He X
Mol Med Rep; 2016 Jul; 14(1):1019-25. PubMed ID: 27222255
[TBL] [Abstract][Full Text] [Related]
2. lncRNA ROR promotes the progression of renal cell carcinoma through the miR‑206/VEGF axis.
Shi J; Zhang D; Zhong Z; Zhang W
Mol Med Rep; 2019 Oct; 20(4):3782-3792. PubMed ID: 31485634
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑222‑3p promotes tumor cell migration and invasion and inhibits apoptosis, and is correlated with an unfavorable prognosis of patients with renal cell carcinoma.
Zhao L; Quan J; Li Z; Pan X; Wang J; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Chen Y; Lai Y
Int J Mol Med; 2019 Jan; 43(1):525-534. PubMed ID: 30320376
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of Serum lncRNA Cancer Susceptibility Candidate 2 (CASC2) for Chronic Renal Failure in Patients with Type 2 Diabetes.
Wang L; Su N; Zhang Y; Wang G
Med Sci Monit; 2018 Sep; 24():6079-6084. PubMed ID: 30171178
[TBL] [Abstract][Full Text] [Related]
5. Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.
Seles M; Hutterer GC; Kiesslich T; Pummer K; Berindan-Neagoe I; Perakis S; Schwarzenbacher D; Stotz M; Gerger A; Pichler M
Int J Mol Sci; 2016 Apr; 17(4):573. PubMed ID: 27092491
[TBL] [Abstract][Full Text] [Related]
6. The functions of long non-coding RNA (lncRNA)-MALAT-1 in the pathogenesis of renal cell carcinoma.
Anbiyaee O; Moalemnia A; Ghaedrahmati F; Shooshtari MK; Khoshnam SE; Kempisty B; Halili SA; Farzaneh M; Morenikeji OB
BMC Nephrol; 2023 Dec; 24(1):380. PubMed ID: 38124072
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA CASC2 induces apoptosis and autophagy in human colon cancer cells via modulation of TRIM16 expression.
Ju B; Liu Z; Nai C; Zhu X
Am J Transl Res; 2020; 12(6):2695-2702. PubMed ID: 32655801
[TBL] [Abstract][Full Text] [Related]
8. The expression of lncRNAs CASC2, NEAT1, LINC00299 in breast cancer tissues and their relationship with the XBP1 splicing rate in Iranian patients during 2014-2019: A cross-sectional study.
Orak G; Rezaei HB; Ameli F; Maghsoodi F; Cheraghzade M; Adelipour M
Health Sci Rep; 2023 Sep; 6(9):e1552. PubMed ID: 37706018
[TBL] [Abstract][Full Text] [Related]
9. Lnc-CC3 increases metastasis in cervical cancer by increasing Slug expression.
Jiang B; Sun R; Fang S; Qin C; Pan X; Peng L; Li Y; Li G
Oncotarget; 2016 Jul; 7(27):41650-41661. PubMed ID: 27223436
[TBL] [Abstract][Full Text] [Related]
10. Roles of long noncoding RNAs in gastric cancer and their clinical applications.
Sun W; Yang Y; Xu C; Xie Y; Guo J
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2231-7. PubMed ID: 27246953
[TBL] [Abstract][Full Text] [Related]
11. The Long Noncoding RNA MALAT-1 Is Highly Expressed in Ovarian Cancer and Induces Cell Growth and Migration.
Zhou Y; Xu X; Lv H; Wen Q; Li J; Tan L; Li J; Sheng X
PLoS One; 2016; 11(5):e0155250. PubMed ID: 27227769
[TBL] [Abstract][Full Text] [Related]
12. Expression quantitative trait loci in long non-coding RNA PAX8-AS1 are associated with decreased risk of cervical cancer.
Han J; Zhou W; Jia M; Wen J; Jiang J; Shi J; Zhang K; Ma H; Liu J; Ren J; Dai M; Hu Z; Hang D; Li N; Shen H
Mol Genet Genomics; 2016 Aug; 291(4):1743-8. PubMed ID: 27225188
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA LINC00628 functions as a gastric cancer suppressor via long-range modulating the expression of cell cycle related genes.
Zhang ZZ; Zhao G; Zhuang C; Shen YY; Zhao WY; Xu J; Wang M; Wang CJ; Tu L; Cao H; Zhang ZG
Sci Rep; 2016 Jun; 6():27435. PubMed ID: 27272474
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of lncRNA AFAP1-AS1 correlates with poor prognosis and promotes tumorigenesis in colorectal cancer.
Wang F; Ni H; Sun F; Li M; Chen L
Biomed Pharmacother; 2016 Jul; 81():152-159. PubMed ID: 27261589
[TBL] [Abstract][Full Text] [Related]
15. The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis.
Iden M; Fye S; Li K; Chowdhury T; Ramchandran R; Rader JS
PLoS One; 2016; 11(5):e0156274. PubMed ID: 27232880
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression.
Nie F; Yu X; Huang M; Wang Y; Xie M; Ma H; Wang Z; De W; Sun M
Oncotarget; 2017 Jun; 8(24):38227-38238. PubMed ID: 27246976
[TBL] [Abstract][Full Text] [Related]
17. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W
J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915
[TBL] [Abstract][Full Text] [Related]
18. The long noncoding RNA HOTAIR activates autophagy by upregulating ATG3 and ATG7 in hepatocellular carcinoma.
Yang L; Zhang X; Li H; Liu J
Mol Biosyst; 2016 Jul; 12(8):2605-12. PubMed ID: 27301338
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MALAT1 exerts oncogenic functions in lung adenocarcinoma by targeting miR-204.
Li J; Wang J; Chen Y; Li S; Jin M; Wang H; Chen Z; Yu W
Am J Cancer Res; 2016; 6(5):1099-107. PubMed ID: 27294002
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway.
Li SP; Xu HX; Yu Y; He JD; Wang Z; Xu YJ; Wang CY; Zhang HM; Zhang RX; Zhang JJ; Yao Z; Shen ZY
Oncotarget; 2016 Jul; 7(27):42431-42446. PubMed ID: 27285757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
